Published May 18, 2022 | Version v1
Report Open

Contextual factors influencing intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) uptake

  • 1. Emory University, Atlanta, United States of America
  • 2. Liverpool School of Tropical Medicine, Liverpool, United Kingdom
  • 3. Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, United States of America

Description

Report considered by the WHO/GMP Guideline Development Group on Malaria Chemoprevention for “Section 4.2.1 Intermittent preventive treatment of malaria in pregnancy (IPTp)” of the WHO Guidelines for malaria, 3 June 2022.

Files

Rodriguez-et-al-2022-contextual-factors-influencing-IPTp-SP-uptake.pdf